Vycor Medical (VYCO) Liabilities and Shareholders Equity (2022 - 2023)
Vycor Medical (VYCO) has disclosed Liabilities and Shareholders Equity for 6 consecutive years, with $1.1 million as the latest value for Q3 2023.
- Quarterly Liabilities and Shareholders Equity rose 11.02% to $1.1 million in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $2.8 million through Dec 2023, down 23.49% year-over-year, with the annual reading at $860178.0 for FY2022, N/A changed from the prior year.
- Liabilities and Shareholders Equity for Q3 2023 was $1.1 million at Vycor Medical, up from $905438.0 in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $1.1 million in Q3 2023, with the low at $835156.0 in Q1 2023.